Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
May 29, 2013 -- Valeant Pharma, Canada’s largest drugmaker, announced yesterday it would pay $8.7 billion to acquire Bausch & Lomb. With the transaction, Valeant bought a substantial portfolio of eye care products, but it also acquired, for the first time, a sales foothold in China. Valeant said it would leverage B&L’s China organization to bring its own products to the PRC. More details....
Stock Symbol: (NYSE: VRX)
Help employers find you! Check out all the jobs and post your resume.
